Cache Advisors’s Corcept Therapeutics CORT Stock Holding History

Cache Advisors’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$652K	Hold	7,500	–	–	0.06%	92
2026 Q1	$302K	Hold	7,500	–	–	0.03%	102
2025 Q4	$261K	Hold	7,500	–	–	0.03%	105
2025 Q3	$623K	Hold	7,500	–	–	0.11%	63
2025 Q2	$551K	Hold	7,500	–	–	0.15%	62
2025 Q1	$857K	Hold	7,500	–	–	0.33%	42
2024 Q4	$378K	Buy	+7,500	New	+$393K	0.16%	58

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cache Advisors's CORT Position: Q2 2026 in Review

Cache Advisors held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 7,500 shares worth $652K. The position accounts for 0.06% of the portfolio, ranked #92.

Cache Advisors first reported a position in CORT in Q4 2024 and has held it in 7 quarters since. The position peaked at $857K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Cache Advisors held 7,500 shares of Corcept Therapeutics worth $652K as of Q2 2026.
Cache Advisors left its Corcept Therapeutics share count unchanged in Q2 2026.
Corcept Therapeutics made up 0.06% of Cache Advisors's portfolio in Q2 2026, its #92 holding.
Cache Advisors first reported a position in Corcept Therapeutics in Q4 2024 and has held it in 7 quarters since.
Cache Advisors's Corcept Therapeutics position peaked at $857K in Q1 2025.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Cache Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.